To address these issues, we engineered lactoferrin-encapsulated cyanidin-3-glucoside nanoparticles (LF-C3GNPs) using electrohydrodynamic nanotechnology for the management of oxidative-inflammatory disorders in mastitis. Here, LTF is linked to mastitis.